You have 9 free searches left this month | for more free features.

Ototoxicity

Showing 1 - 25 of 163

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cancer, Ototoxicity, Drug-Induced, Quality of Life Trial (Patients suffering from chemo-induced ototoxicity)

Not yet recruiting
  • Cancer
  • +3 more
  • Patients suffering from chemotherapy-induced ototoxicity
  • (no location specified)
Jun 29, 2023

Head Neck Cancer Survivors, Head Neck Cancer Surviors Trial in Saint Louis (Ototoxicity Screening Protocol)

Not yet recruiting
  • Head and Neck Cancer Survivors
  • Cancer of the Head and Neck Surviors
  • Ototoxicity Screening Protocol
  • Saint Louis, Missouri
    Washington University School of Medicine
Mar 16, 2023

Radiosurgery Induced Ototoxicity in Patients Treated

Recruiting
  • Vestibular Schwannoma
  • Ototoxicity
  • Stereotactic radiosurgery
  • Geneva, Switzerland
    Service d'ORL et Chirurge cervico-faciale, Hopitaux Universitair
Nov 30, 2022

Hearing Loss Ototoxic Trial (SENS-401 (R-Azasetron Besylate))

Not yet recruiting
  • Hearing Loss Ototoxic
  • SENS-401 (R-Azasetron Besylate)
  • (no location specified)
Nov 16, 2022

Aminoglycoside Toxicity, Aminoglycoside-Induced Hearing Loss, Hearing Loss Trial in London, Poole (video game hearing tests,

Recruiting
  • Aminoglycoside Toxicity
  • +3 more
  • video game hearing tests
  • Audio-training
  • London, United Kingdom
  • +1 more
May 11, 2023

Ototoxicity Trial in Charleston (Placebo, SPI-1005 Ebselen 200mg Capsule x1, SPI-1005 Ebselen 200mg Capsule x2)

Enrolling by invitation
  • Ototoxicity
  • Placebo
  • +3 more
  • Charleston, South Carolina
    Medical University of South Carolina
Dec 7, 2022

Ototoxic Hearing Loss Trial in Toronto (N-Acetyl Cysteine)

Recruiting
  • Ototoxic Hearing Loss
  • N-Acetyl Cysteine
  • Toronto, Ontario, Canada
    Odette Cancer Centre, Sunnybrook Health Sciences Centre
Oct 24, 2022

Ototoxicity, Drug-Induced Trial in Cincinnati (Sodium Thiosulfate)

Recruiting
  • Ototoxicity, Drug-Induced
  • Sodium Thiosulfate
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Mar 6, 2023

Ototoxicity, Drug-Induced Trial in United States (ORC-13661, Placebo)

Not yet recruiting
  • Ototoxicity, Drug-Induced
  • Denver, Colorado
  • +4 more
Feb 7, 2023

Other Disorders of Vestibular Function, Bilateral, Bilateral Vestibular Deficiency (BVD), Gentamicin Ototoxicity Trial in

Not yet recruiting
  • Other Disorders of Vestibular Function, Bilateral
  • +9 more
  • Labyrinth Devices MVI™ Multichannel Vestibular Implant System
  • Baltimore, Maryland
    Johns Hopkins School of Medicine
Jan 5, 2023

Other Disorders of Vestibular Function, Bilateral, Bilateral Vestibular Deficiency (BVD), Gentamicin Ototoxicity Trial in

Not yet recruiting
  • Other Disorders of Vestibular Function, Bilateral
  • +8 more
  • Labyrinth Devices MVI™ Multichannel Vestibular Implant System
  • Baltimore, Maryland
    Johns Hopkins School of Medicine
Jan 5, 2023

Cisplatin Adverse Reaction Trial in Cairo (Rosuvastatin 10mg)

Recruiting
  • Cisplatin Adverse Reaction
  • Rosuvastatin 10mg
  • Cairo, Egypt
    Kasr El-Aini Center of Radiation Oncology and Nuclear Medicine
Jul 26, 2021

Mucositis, Nephrotoxicity, Ototoxicity Trial in United States (Tempol, Placebo Solution)

Recruiting
  • Mucositis
  • +2 more
  • La Jolla, California
  • +8 more
Feb 2, 2022

Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV

Recruiting
  • Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +28 more
  • San Francisco, California
    University of California, San Francisco
Dec 16, 2022

Other Disorders of Vestibular Function, Bilateral, Bilateral Vestibular Deficiency (BVD), Gentamicin Ototoxicity Trial in

Recruiting
  • Other Disorders of Vestibular Function, Bilateral
  • +5 more
  • Labyrinth Devices MVI™ Multichannel Vestibular Implant
  • Baltimore, Maryland
    Johns Hopkins School of Medicine
Aug 31, 2021

Brain Tumor, Medulloblastoma, Pineoblastoma Trial in Boston, Houston (proton beam radiation)

Active, not recruiting
  • Brain Tumor
  • +2 more
  • proton beam radiation
  • Boston, Massachusetts
  • +1 more
Sep 30, 2021

Brain Tumor, Low Grade Glioma, Astrocytoma Trial in Boston (Proton radiotherapy)

Active, not recruiting
  • Brain Tumor
  • +4 more
  • Proton radiotherapy
  • Boston, Massachusetts
  • +1 more
Sep 30, 2021

Osteosarcoma, Nephrotoxicity, Ototoxicity Trial in Philadelphia (Pantoprazole, High-dose methotrexate infusion duration)

Completed
  • Osteosarcoma
  • +2 more
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Mar 2, 2020

QoL From Ototoxicity in Cancer Survivors

Suspended
  • Hearing Loss, Sensorineural
  • +3 more
  • High frequency pure tone audiometry
  • Nottingham, Nottinghamshire, United Kingdom
    Nottingham University Hospitals NHS trust
Mar 24, 2020

Quality of Life of Long-term Ototoxicity in Cancer Survivors

Completed
  • Quality of Life
  • +4 more
  • High frequency audiometry
  • +3 more
  • Nottingham, Nottinghamshire, United Kingdom
    University of Nottingham
Mar 24, 2020

Cisplatin Induced Hearing Loss Trial in San Diego (OTO-104)

Terminated
  • Cisplatin Induced Hearing Loss
  • San Diego, California
    Contact Otonomy call center for trial locations
Sep 14, 2020

Medulloblastoma Trial (drug, other, radiation)

Recruiting
  • Medulloblastoma
  • Madera, California
  • +1 more
Jan 30, 2023

Cisplatin Ototoxicity, Hearing Loss Trial in Portland (COMP-VA, Standard of care)

Completed
  • Cisplatin Ototoxicity
  • Hearing Loss
  • COMP-VA
  • Standard of care
  • Portland, Oregon
    VA Portland Health Care System, Portland, OR
Sep 17, 2019

Web and Tablet-based Interactive Audiometry in Adults With CF

Completed
  • Hearing Loss, Sensorineural
  • Cystic Fibrosis
  • Audiometry tablet diagnostic tool and web-based test
  • London, United Kingdom
    Dr Anand Shah
May 22, 2020

Cancer and Hearing Loss Related in Children

Completed
  • Cancer in Children
  • Hearing Loss
  • Genetic study
  • Genetic study MT-RN1
  • Paris, France
    Institut Curie
Apr 30, 2021